FDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder
FDA-approved Orzeyful, the first narcolepsy type 1 drug that restores orexin signaling instead of treating symptoms one at a time.
Medical Daily ·